SJQClass II
Immunoassay For Host Biomarkers To Predict Risk Of 28-Day All-Cause Mortality In Patients With Sepsis And Septic Shock.
21 CFR 866.3215 / Microbiology
Classification record
- Product code
- SJQ
- Device name
- Immunoassay For Host Biomarkers To Predict Risk Of 28-Day All-Cause Mortality In Patients With Sepsis And Septic Shock.
- FDA definition
- An immunoassay used to detect host biomarkers as an aid to assess the risk of 28-day all-cause mortality in patients with sepsis and septic shock.
- Regulation
- 21 CFR 866.3215
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- Yes
- Ingested clearances
- 1
- Ingested recalls
- 0
Clearances, product code SJQ
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2026 | 1 |
Applicants with the most clearances
Product code SJQ| Applicant | Clearances |
|---|---|
| B·R·A·H·M·S GmbH (part of Thermo Fisher Scientific) | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeNo registered establishment in MDM’s records lists product code SJQ.
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
